SCHEMBL25002133

SCHEMBL25002133

CCOC(=O)/N=c1\scc(CO)n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
POLB P06746 2/20 0.47
GAA P10253 2/20 0.47
MAPK1 P28482 1/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TSHR P16473 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
GSK3B P49841 1/20 0.43
ATM Q13315 1/20 0.43
RAB9A P51151 2/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 1/20 0.38
HCRTR1 O43613 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30130842 0.92 ALDH1A1 (0.47) ALDH1A1POLBGAAMAPK1MEN1
SCHEMBL23749768 0.83 ALDH1A1 (0.47) ALDH1A1POLBGAAMAPK1MEN1
SCHEMBL23749770 0.81 ALDH1A1 (0.45) ALDH1A1POLBGAAMAPK1MEN1
SCHEMBL25002132 0.81 MAPT (0.48) ALDH1A1POLBGAAMAPK1MEN1
SCHEMBL23749889 0.81 ALDH1A1 (0.44) ALDH1A1POLBGAAMAPK1MEN1
SCHEMBL23727789 0.77 RAB9A (0.45) ALDH1A1POLBMAPK1MEN1KMT2A
SCHEMBL23727791 0.77 RAB9A (0.45) ALDH1A1POLBMAPK1MEN1KMT2A
SCHEMBL25002139 0.77 ALDH1A1 (0.47) ALDH1A1GAAKMT2AMAPTLMNA
SCHEMBL30168298 0.77 ALDH1A1 (0.47) ALDH1A1GAAKMT2AMAPTLMNA
SCHEMBL23750082 0.74 ALDH1A1 (0.56) ALDH1A1POLBGAAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343726-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION THE ROCKEFELLER UNIVERSITY (US) 2024-10-17 US disclosed
WO-2023015156-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION HUDSPETH A JAMES (US) 2023-02-09 WO disclosed
WO-2023015156-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION HUDSPETH A JAMES (US) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343726-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION LATS1, LATS2, YAP1 ALDH1A1 3828/4885POLB 1432/4885GAA 4064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.